TITLE
Effect of FGF19 and TNFalpha on human DU145 prostate cancer cells

ORGANISM
Homo sapiens

SUMMARY
DU145 prostate cancer cells were treated with 50 ng/ml FGF19 and 50 ug/ml heparin, or 10 ng/ml TNFalpha, or both

DESIGN
drug treatment groups

